{'fraction_non_alphanumeric': 0.02631578947368421, 'fraction_numerical': 0.011961722488038277, 'mean_word_length': 4.739726027397261, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Platelets-to-lymphocyte ratio and esophageal cancer.

We read with great interest the recent publication by Deng et al . (1) published in the March 2018 issue of Journal of Thoracic Disease . The authors have performed a meta-analysis in order to examine the role of platelet to lymphocyte ratio (PLR) in the prognosis of esophageal cancer and also to evaluate the relationship with tumor pathological characteristics.